Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
MEKINIST
(trametinib)Orphan drugstandardNovartis Pharmaceuticals Corp.
12.1 Mechanism of Action Trametinib is a reversible inhibitor of mitogen-activated extracellular signal-regulated kinase 1 (MEK1) and MEK2 activation ...
Browse all Congenitally uncorrected transposition of the great arteries with coarctation news →
View all Congenitally uncorrected transposition of the great arteries with coarctation specialists →